Updated Meaningful Use rules maintain focus on transitions of care
With proper preparations, hospitals can ensure the transition to MU3 is as streamlined as possible.
With proper preparations, hospitals can ensure the transition to MU3 is as streamlined as possible.
You really have to feel for those whose points of contention at the Thanksgiving dinner table include health IT.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
The letters, signed by 111 groups, rapped the Obama administration for sticking to what the signatories called "fundamental flaws" in Meaningful Use regulations that they believe are more about documentation than promoting interoperability of electronic health records.
As a palliative care physician, I’m not really a technology guy. My choices in gizmos reflect this…the intuitive Apple computer, Zoom videoconferencing, athenahealth’s EMR, etc… My view of “meaningful use” is very different than that of the Department of Health and Human Services. While they define “meaningful” with a carrot and a stick, I tend […]
The final rules are not substantially different than the proposed rules, but the thresholds have been reduced.
HHS officials late Tuesday released the long-awaited Stage 3 rules, as well as modifications to the current Stage 2, shortening the reporting period for many healthcare providers.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Patient visits to ambulatory surgery centers would be exempt from Meaningful Use reporting — and related Medicare penalties — for the physicians and other "elgibile professionals" who see them starting next year, under legislation that unanimously passed the Senate this week.
With a mere 461 days until the 2016 election, the partisan divide is as acute as ever, but here's a hopeful sign that Washington occasionally works: Dr. Karen DeSalvo will get a hearing this week on her nomination to be assistant secretary for health in the Department of Health and Human Services.
Rep. Renee Elmers (R-N.C.) on Thursday introduced legislation that would prevent the Centers for Medicare and Medicaid Services from even writing the final Stage 3 Meaningful Use rules until at least 2017. It also would permanently shorten the annual attestation period to 90 days, rather than the full year, and institute a "linear scale" next year for compliance to replace the current all-or-nothing nature of the EHR incentive program.
Despite all the talk of interoperability among policy-makers, providers and even technology vendors, today's crop of electronic health records will continue to be "fortress" applications that hinder information sharing until incentives change and, perhaps most importantly, end users demand interoperable systems, according to a new Chilmark Research report.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Dr. Jon White, deputy national coordinator in the Office of the National Coordinator for Health Information Technology has seen it all in health IT.
The former CFO of a Texas hospital implicated in a scheme to defraud the Meaningful Use health IT incentive program has been sentenced to 23 months in federal prison and ordered to pay nearly $4.5 million.
Many of you have probably heard of the proposed reporting rule for Meaningful Use Stage 2. In this proposed rule, CMS announced their intent to align the remaining years of the Stage 2 with the proposed rule for Meaningful Use Stage 3 released in March. How will this affect those involved in care transitions? More time to report […]
Oh, mainstream media. Your incessant need to oversimplify things is confusing the public and making it impossible to have an honest, informed debate about reforming our nation's bloated and dangerous healthcare industry.
Even with a 2018 deadline, increasing transitions of care requirements seems very optimistic.